Clinical Stage B Non-seminomatous Germ Cell Testis Cancer: The Indiana University Experience (1965-1989) Using Routine Primary Retroperitoneal Lymph Node Dissection

By Donohue J.P.   Thornhill J.A.   Foster R.S.   Rowland R.G.   Bihrle R.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1599-1604

Elsevier

Access to resources Recommend Favorite

Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT)

By Donohue J.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

Changes in the Incidence and Mortality of Testicular Cancer in Scotland with Particular Reference to the Outcome of Older Patients Treated for Non-seminomatous Germ Cell Tumours

By Hatton M.Q.F.   Paul J.   Harding M.   MacFarlane G.   Robertson A.G.   Kaye S.B.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1487-1491

Elsevier

Access to resources Recommend Favorite

Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer

By Araujo Antonio   Mendez Jose   Coelho Ana   Sousa Berta   Barata Fernando   Figueiredo Ana   Amaro Teresina   Azevedo Isabel   Soares Marta  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer – a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

By Haugnes Hege S.   Laurell Anna   Stierner Ulrika   Bremnes Roy M.   Dahl Olav   Cavallin-Ståhl Eva   Cohn-Cedermark Gabriella  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 168-176

Informa Healthcare

Access to resources Recommend Favorite